The aim of this book will be to contribute to the education of a new generation of experts in urology, molecular biology, pathology and oncology, offering them sufficient knowledge in basic and translational research to be fluency in the web of interacting networks playing a role in prostate cancer development, progression, metastasis and drug-resistance. The volume will cover the latest innovative researches in prostate cancer, with particular emphasis to the state-of-the-art analysis technologies that are essential for the accurate identification of molecular targets for disease diagnosis, molecular mechanisms of tumorigenesis, markers for susceptibility, molecular-based prognostic prevision, characterization of biomarkers of drug efficacy and drug resistance, validation of new therapeutics and diagnostics. Current advancements on the intersecting data concerning transcriptomes, proteomes, the molecular techniques referred as "omes", will be reported and discussed.
Inhaltsverzeichnis
From the reviews:
A valuable compendium of salient topics in prostate cancer, this book encompasses the field, from diagnostic and prognostic criteria to current therapeutic approaches, while also offering valuable background in molecular pathology, genetics, and epigenetics. ideally directed to urologists aiming to learn more about the intricacies of prostate cancer at the cellular and molecular level as well as bench scientists and biologists with an interest in a comprehensive perspective on the disease. (Alessandro Fatatis, Doody s Book Reviews, January, 2014)Es wurden noch keine Bewertungen abgegeben. Schreiben Sie die erste Bewertung zu "Prostate Cancer: Shifting from Morphology to Biology" und helfen Sie damit anderen bei der Kaufentscheidung.
